APA
Stöhr R., Brandenburg V. M., Heine G. H., Maeder M. T., Leibundgut G., Schuh A., Jeker U., Pfisterer M., Sanders-van Wijk S. & Brunner-la Rocca H. (20210517). Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial. : European journal of heart failure.
Chicago
Stöhr Robert, Brandenburg Vincent M, Heine Gunnar H, Maeder Micha T, Leibundgut Gregor, Schuh Alexander, Jeker Urs, Pfisterer Matthias, Sanders-van Wijk Sandra and Brunner-la Rocca Hans-Peter. 20210517. Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial. : European journal of heart failure.
Harvard
Stöhr R., Brandenburg V. M., Heine G. H., Maeder M. T., Leibundgut G., Schuh A., Jeker U., Pfisterer M., Sanders-van Wijk S. and Brunner-la Rocca H. (20210517). Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial. : European journal of heart failure.
MLA
Stöhr Robert, Brandenburg Vincent M, Heine Gunnar H, Maeder Micha T, Leibundgut Gregor, Schuh Alexander, Jeker Urs, Pfisterer Matthias, Sanders-van Wijk Sandra and Brunner-la Rocca Hans-Peter. Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial. : European journal of heart failure. 20210517.